# Zydus Hospira Oncology Private Ltd., Matoda, India – FDA Inspections

Source: https://www.keypedia.com/companies/zydus-hospira-oncology-private-ltd/1daf2047-24d1-4343-9500-8a3c69eccaf4

> Inspection records and compliance data for Zydus Hospira Oncology Private Ltd. in Matoda. 5 FDA inspections on record, 2 Form 483s, last inspected June 30, 2023.

---

## Details

- Name: Zydus Hospira Oncology Private Ltd.
- FEI Number: 3007869619
- Business Operations: FDF MANUFACTURE
- Address Line 1: Pharmez Plot No 3, Special Economic Zone; Sarkhej - Bavla Highway
- City: Matoda
- Country Name: India
- Address: Pharmez Plot No 3, Special Economic Zone; Sarkhej - Bavla Highway, Matoda, India
- Country: India

## Related Documents

- [FDA Inspection 1209538 - Zydus Hospira Oncology Private Ltd. - 2023-06-30](https://www.keypedia.com/records/fda_inspections/zydus-hospira-oncology-private-ltd/7b59ae6f-187d-47e6-b77e-fa45f958bba5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2023
- [FDA Inspection 1107385 - Zydus Hospira Oncology Private Ltd. - 2019-10-22](https://www.keypedia.com/records/fda_inspections/zydus-hospira-oncology-private-ltd/45367c8e-d0a9-4d85-98cc-02abfd4cebe6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2019
- [FDA Inspection 1048779 - Zydus Hospira Oncology Private Ltd. - 2018-04-12](https://www.keypedia.com/records/fda_inspections/zydus-hospira-oncology-private-ltd/5353f90a-015e-4e40-905f-ca883f90d753) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 12, 2018
- FDA Inspection 899318 - Zydus Hospira Oncology Private Ltd. - 2014-09-16 — classification: No Action Indicated (NAI), source: FDA, date: September 16, 2014
- FDA Inspection 794202 - Zydus Hospira Oncology Private Ltd. - 2012-07-26 — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2012

## Related Companies

- [Boehringer Ingelheim Espana S.A.](https://www.keypedia.com/companies/boehringer-ingelheim-espana-sa/afd6c8fe-92cc-4db4-8157-94020bcf06d6)
- [R-Pharm Germany GmbH](https://www.keypedia.com/companies/r-pharm-germany-gmbh/00237a65-957b-4892-abce-2844ed37acda)
- [ANSTO Nuclear Medicine](https://www.keypedia.com/companies/ansto-nuclear-medicine/9bb26b43-b1c1-4d57-9008-7563e01d67e2)
- [Visum Pharmaceutical Co Ltd](https://www.keypedia.com/companies/visum-pharmaceutical-co-ltd/304efe69-24b4-4b93-aece-f7addcc5e21c)
- [Opella Healthcare International SAS](https://www.keypedia.com/companies/opella-healthcare-international-sas/53ed93ee-b631-49a0-bba2-a57194143394)
- [EirGen Pharma Ltd](https://www.keypedia.com/companies/eirgen-pharma-ltd/f9a682ae-b665-4341-814c-af610c74a3ec)
- [Polygen Pharmaceuticals Inc.](https://www.keypedia.com/companies/polygen-pharmaceuticals-inc/d7df0d1f-787a-4629-b096-255e664d26ef)
- [Citragen Pharmaceuticals Inc](https://www.keypedia.com/companies/citragen-pharmaceuticals-inc/c9428b65-fa89-4165-8df5-4b2ae89afc03)
- [Sofgen Pharmaceuticals LLC](https://www.keypedia.com/companies/sofgen-pharmaceuticals-llc/4bf867c1-4886-43a8-b3a1-3d027c2307b8)
- [CorePharma, LLC](https://www.keypedia.com/companies/corepharma-llc/037e485c-5d38-40e3-80fe-b00a72cda489)